Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amicus (FOLD – Research Report), Azenta (AZTA – Research Report) and ImmunoGen (IMGN – Research Report). Amicus (FOLD) Berenberg Bank analyst Zhiqiang Shu maintained a Hold rating on Amicus today and set a price target of $11.00. The company's shares closed last Monday at $6.23, close to its 52-week low of $5.91. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-amicus-fold-azenta-azta-and-immunogen-imgn?utm_source=advfn.com&utm_medium=referral
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more ImmunoGen Charts.
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more ImmunoGen Charts.